Аssociations of vascular endothelial growth factor-A with hemodynamic data in patients after ST-elevation myocardial infarction
Article Sidebar
Main Article Content
Abstract
The aim – to research associations between vascular endothelial growth factor-A (VEGF-A) level and left ventricular remodeling after ST elevation myocardial infarction (MI).
Material and methods. 62 patients with MI, 51 (82.3 %) male and 11 (17.7 %) female at average age 58.63±8.90 years were enrolled into the study. VEGF-A level was determined on the 7th day of MI by enzyme-linked immunoassay. Anxiety level was assessed by Taylor questionnaire during the period of 10–14 days before MI. After 6-month observation 47 patients were assessed.
Results. In patients with MI in comparison with the control group significant rise of serum VEGF-A level was observed, showing positive correlation with creatine kinase level. The level of VEGF-A below median 160 pg/ml in comparison with its level above the median 160 pg/ml was associated with higher frequency of MI in men (Р=0.023), anxiety before MI (Р=0.019), end diastolic diameter (EDD), end systolic diameter (ESD), end diastolic volume (EDV) increase in acute phase, EDD, ESD, EDV, left ventricular myocardial mass, Е/А, lower exercise tolerance after 6-month observation. This processes indicates unfavorable role of low VEGF-A levels and protective – of high VEG-A levels for intracardiac hemodynamic after myocardial infarction. The level of VEGF-A ≤ 201.86 pg/ml with sensitivity 57.9 % and specificity 85.7 % (AUC 0.711; 95 % CI 0.513–0.908; Р=0.036) have prognostic significance for adverse remodeling development.
Conclusions. VEGF-A level – important indicator to estimate the extent of myocardial injury and pathologic remodeling development.
Article Details
Keywords:
References
Roslavtseva VV, Salmina AB, Prokopenko SV. The role of vascular endothelial growth factor in the regulation of development and functioning of the brain: new target molecules for pharmacotherapy. Biomedicinskaia chimiia [Biomedical Chemistry] 2016; 62(2):124–33. Doi: https://doi.org/10.1809/PBMC20166202124 (in Russ).
Sisakyan AS, Oganyan VA, Semerdzhyan AB, Petrosyan MV, Sisakyan SA, Gurevich M.A. Vliyanie faktora angiogeneza na morfofunkcionalnoe sostoyanie miokarda u krys pri eksperimentalnom infarkte miokarda. Rossijskij kardiologicheskij zhurnal [Russian Cardiology journal] 2008; 2:63–6 (in Russ). https://russjcardiol.elpub.ru/jour/article/view/1554/1264
Teplyakov AT, Berezikova EN, Shilov SN, Grakova EV, Torim YuYu, Efremova AV. Patogeneticheskaya i prognosticheskaya znachimost rostovyh faktorov v razvitii hronicheskoj serdechnoj nedostatochnosti. Kardiologiya [Cardiology] 2017; 57(10):20–8. DOI: https://doi.org/10.18087/cardio.2017.10.10039 (in russ)
Chumakova OS, Tipteva TA, Reznichenko NE, Zatejshikov DA Associaciya arterialnoj gipertenzii, oslozhnennoj gipertrofiej miokarda i serdechnoj nedostatochnostyu, s bolee nizkimi urovnyami faktora rosta endoteliya sosudov (VEGF-165) v syvorotke krovi. Kardiologiya [Cardiology] 2015; 10:14–8. DOI: https://doi.org/10.18565/Cardio.2015.10.14-18 (in russ)
Chintalgattu V, Nair DM, Katwa LC. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol. 2003 Mar;35(3):277–86. PubMed PMID: 12676542. https://www.ncbi.nlm.nih.gov/pubmed/12676542
Devaux Y, Vausort M, Azuaje F, Vaillant M, Lair ML, Gayat E, Lassus J, Ng LL, Kelly D, Wagner DR, Squire IB. Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction. J Card Fail. 2012; 18(4):330–37. Doi: https://doi.org/10.1016/j.cardfail.2012.01.010.
Elfving B, Buttenschøn HN, Foldager L, Poulsen PH, Grynderup MB, Hansen ÅM, Kolstad HA, Kaerlev L, Mikkelsen S, Børglum AD, Wegener G, Mors O. Depression and BMI influences the serum vascular endothelial growth factor level. International Journal of Neuropsychopharmacology. 2014; Sep; 17(9): 1409–17. Doi: https://doi.org/10.1017/S1461145714000273
Ferrara N. Binding to the extracellular matrix and proteolytic processing. Two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell. 2010 Mar 1;21(5):687-90. doi: https://doi.org/10.1091/mbc.E09-07-0590
Ferrara N. Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 2009; 29(6):789–91. Doi: https://doi.org/10.1161/ATVBAHA.108.179663.
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharm Rew 2004; 56(4): 549–80. Doi: http://doi.org/10.1124/pr.56.4.3.
Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T, Shimada K. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000; 35(4): 968-73. PMID: 10732896 https://www.ncbi.nlm.nih.gov/pubmed/10732896
Korybalska K, Pyda M, Kawka E, Grajek S, Bręborowicz A, Witowski J. Interpretation of elevated serum VEGF concentration in patients with myocardial infarction. Cytokine 2011; 54(1): 74–8. DOI: https://doi.org/10.1016/j.ijcard.2012.05.103
Kranz A, Rau C, Kochs M, Waltenberger J. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 2000; 32(1):65–72. Doi: http://doi.org/10.1006/jmcc.1999.1062
Maingrette F, Dussault S, Dhahri W, Desjarlais M, Mathieu R, Turgeon J, Haddad P, Groleau J, Perez G, Rivard A. Psychological stress impairs ischemia-induced neovascularization: protective effect of fluoxetine. Atherosclerosis. 2015; Aug; 241(2): 569-578. Doi: http://doi.org/10.1016/j.atherosclerosis.2015.06.010. Epub 2015 Jun 9.
Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, et al. Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month outcome. Resuls from Nagoya Acute Myocardial Infarction Study. Circ J. 2012; 76:1509-16. DOI: http://doi.org/10.1253/circj.CJ-11-1127.
Niu J, Han X, Qi H, Yin J, Zhang Zhiq, Zhang Zen, et al. Correlation between vascular endothelial growth factor and long-term prognosis in patients with acute myocardial infarction. Exp and Ther Med. 2016; April, 21; 12(1):475-479. DOI: http://doi.org/10.3892/etm.2016.3286.
Ogawa H, Suefuji H, Soejma H, Nishiyama K, Misumi K, Takazoe K, et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology. 2000; 93(1-2): 93-9. Doi: 7008. http://doi.org/10.1159/000007008
Ramos K, Napoleao P, Selas M, Freixo C, Viegas Crespo AM, Carmo MM, et al. Prognostic value of VEGF in patients submitted to percutaneous coronary intervention. Hindawi Publishing Corporation. 2014; Article ID: 135357, 7 pages. DOI: http://doi.org/10.1155/2014/135357.
Rosano J.M., Cheheltani R., Wang B. et al. Targeted delivery of VEGF after a myocardial infarction reduces collagen deposition and improves cardiac feunction //CardiovascEng Technol. -2012. –Vol.3(2). –P.237-247. DOI: http://doi.org/10.1007/s13239-012-0089-3.
Shi C, Zhao Y, Yang Y, Chen C, Hou X, Shao J, et al. Collagen-binding VEGF targeting the cardiac extracellular matrix promotes recovery in porcine chronic myocardial infarction. Biomater Sci. 2018 Jan 30;6(2):356-363. doi: http://doi.org/10.1039/c7bm00891k. PubMed PMID: 29266144.
Shimokawahara H, Jougasaki M, Setoguchi M, Ichiki T, Sonoda M, Nuruki N, et al. Relationsheep between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction. J Cardiol. 2014; Nov; 64(5): 360-65. Doi: http://doi.org/10.1016/j.jjcc.2014.02.017
Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction. Circ J 2002; 66:1003-7. https://www.ncbi.nlm.nih.gov/pubmed/12419930
Taimeh Z, Loughran J, Birks EJ, Bolli R. Vascular endothelial growth factor in heart failure. Nat Rev Cardiol. 2013 Sep;10(9):519-30. doi: http://doi.org/10.1038/nrcardio.2013.94. Epub 2013 Jul 16.
Taylor JA A Personality Scale of Manifest Anxiety. J Abnormal and Social Psych. 1953; 48(2):285-90. https://psycnet.apa.org/record/1954-02683-001
Wallenstein J, Asberg M, Nygen A, Szulkin R., Wallén H, Mobarrez F Possible biomarkers of chronic stress induced exhaustion – a longitudinal study. Plos one. 2016; May, 4; 11(5):e0153924. Doi: http://doi.org/10.1371/journal.pone.0153924
Wang B, Cheheltani R, Rosano J, Crabbe DL, Kiani MF. Targeted delivery of VEGF to treat myocardial infarction. Adv Exp Med Biol. 2013;765:307-314. doi: http://doi.org/10.1007/978-1-4614-4989-8_43. PubMed PMID: 22879049.
Wojakovski W, Maslankiewicz K, Ochala A et al. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina. Int J Mol Med 2004; 14(2): 317-22. Doi: http://doi.org/10.3892/ijmm.14.2.317.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-conrol study. Lancet. 2004; 364(9438): 937-52. Doi: http://doi.org/10.1016/S0140-6736(04)17018-9
Zentilin L, Puligadda U, Lionetti V, Zacchigna S, Collesi C, Pattarini L, Ruozi G, Camporesi S, Sinagra G, Pepe M, Recchia FA, Giacca M. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 2010 May;24(5):1467-78. doi: http://doi.org/10.1096/fj.09-143180. Epub 2009 Dec 17. PubMed PMID: 20019242.